Management of coexisting thyrotropin/growth-hormone-secreting pituitary adenoma and papillary thyroid carcinoma: A therapeutic challenge

Thyroid

Volumn 20, Issue 1, 2010, Pages 99-103

  Nguyen, Huong D ^a   Galitz, Michael S ^b   Mai, Vinh Q ^a   Clyde, Patrick W ^a   Glister, Babette C ^a   Shakir, Mohamed K M ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; INDIUM 111; LEVOTHYROXINE; LIOTHYRONINE; OCTREOTIDE; RADIOACTIVE IODINE; RECOMBINANT THYROTROPIN; SOMATOMEDIN C; THYROGLOBULIN; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; ASPIRATION BIOPSY; CANCER REGRESSION; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CYTOPATHOLOGY; FEMALE; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; GROWTH HORMONE SECRETING ADENOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THYROID PAPILLARY CARCINOMA; THYROID SCINTISCANNING; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; WHOLE BODY CT;

ADENOMA; ANTINEOPLASTIC AGENTS, HORMONAL; CARCINOMA, PAPILLARY; COMBINED MODALITY THERAPY; DELAYED-ACTION PREPARATIONS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; IODINE RADIOISOTOPES; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; OCTREOTIDE; PITUITARY NEOPLASMS; RECOMBINANT PROTEINS; THYROID NEOPLASMS; THYROIDECTOMY; THYROTROPIN; THYROXINE; TREATMENT OUTCOME;

EID: 75149161541     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.0160     Document Type: Article

References (20)

1. Calle-Pascual AL, Yuste E, Martin P, Aramendi T, Garcia-Maurino ML, Argente J, Catalan MJ, Uria J, Cabranes JA, Charro AL 1991 Association of a thyrotropin-secreting pituitary adenoma and a thyroid follicular carcinoma. J Endocrinol Invest 14:499-502.
2. Gasparoni P, Rubello D, Persani L, Beck-Peccoz P 1998 Unusual association between a thyrotropin-secreting pituitary adenoma and a papillary thyroid carcinoma. Thyroid 8:181-183.
3. Kishida M, Otsuka F, Kataoka H, Yokota K, Oishi T, Yamauchi T, Doihara H, Tamiya T, Mimura Y, Ogura T, Makino H 2000 Hyperthyroidism in a patient with TSHproducing pituitary adenoma coexisting with thyroid papillary adenocarcinoma. Endocr J 47:731-738.
4. Ohta S, Nishizawa S, Oki Y, Namba H 2001 Coexistence of thyrotropin-producing pituitary adenoma with papillary adenocarcinoma of the thyroid-a case report and surgical strategy. Pituitary 4:271-274.
5. Beck-Peccoz P, Brucker-Davis F, Persani L, Smallridge R, Weintraub B 1996 Thyrotropin-secreting pituitary tumors. Endocr Rev 17:610-638.
6. Refetoff S, Weiss R, Usala S 1993 The syndromes of resistance to thyroid hormone. Endocr Rev 14:348-399.
7. Brucker-Davis F, Oldfield E, Skarulis M, Doppman J, Weintraub B 1999 Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institute of Health. J Clin Endocrinol Metab 84:476-486.
8. Safer J, Colan S, Fraser L, Wondisford F 2001 A pituitary tumor in a patient with thyroid hormone resistance: a diagnostic dilemma. Thyroid 11:281-291.
9. Beck-Peccoz P, Persani L, Faglia G 1992 Glycoprotein hormone alpha-subunit in pituitary adenoma. Trends Endocrinol Metab 3:41-45.
10. Caron P, Arlot S, Bauters C, Chanson P, Kuhn J, Pugeat M, Marechaud R, Teutsch C, Vidal E, Sassano P 2001 Efficacy of the long-acting octreotide formulation (Octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 86:2849-2853.
11. Beck-Peccoz P, Persani L 2002 Medical management of thyrotropin-secreting pituitary adenomas. Pituitary 5:83-88.
12. Kienitz T, Quinkler M, Strasburger J, Ventz M 2007 Longterm management in five cases of TSH-secreting pituitary adenomas: a single center study and review of the literature. Eur J Endocrinol 157:39-46.
13. Camacho P, Mazzone T 1999 Thyrotropin-secreting pituitary adenoma responsive to bromocriptine therapy. Endocr Pract 5:257-260.
14. Mulinda J, Hasinski S, Rose L 1999 Successful therapy for a mixed thyrotropin-and-prolactin-secreting pituitary macroadenoma with cabergoline. Endocr Pract 5:76-79.
15. Atkinson J, Abboud C, Lane J 2005 Dramatic volume reduction of a large GH=TSH secreting pituitary tumor with short term octreotide therapy. Pituitary 8:89-91.
16. Malarkey W, Kovacs K, O'Dorisio T 1989 Response of a GHand TSH-secreting pituitary adenoma to a somatostatin analogue (SMS 201-995): evidence that GH and TSH coexist in the same cell and secretory granules. Neuroendocrinology 49:267-274.
17. Socin H, Chanson P, Delemer B, Tabarin A, Rohmer V, Mockel J, Stevenaert A, Beckers A 2003 The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. Eur J Endocrinol 148:433-442.
18. Barbaro D, Boni G 2007 Radioiodine ablation of post-surgical thyroid remnants after preparation with recombinant human TSH: why, how, and when. Eur J Surg Oncol 33:535-540.
19. Tuttle RM, Brokhin M, Omry G, Martorella AJ, Larson SM, Grewal RK, Fleisher M, Robbins RJ 2008 Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal. J Nucl Med 49:764-770.
20. Mannavola D, Persani L, Vannucchi G, Zanardelli M, Fugazzola L, Verga U, Facchetti M, Beck-Peccoz P 2005 Different responses to chronic somatostatin analogues in patients with central hyperthyroidism. Clin Endocrinol 62: 176-181.